These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 7007928)
1. [Clinical trial of the activity and therapeutic effectiveness of 3 drugs with diuretic and antihypertensive action]. Tiberi F; Corinaldesi G Minerva Med; 1981 Jan; 72(2):95-100. PubMed ID: 7007928 [TBL] [Abstract][Full Text] [Related]
2. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension. Angelino PF; Alvino-Demartino A; Mappa R; Donati C Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676 [TBL] [Abstract][Full Text] [Related]
3. Moderate sodium restriction and various diuretics in the treatment of hypertension. Ram CV; Garrett BN; Kaplan NM Arch Intern Med; 1981 Jul; 141(8):1015-9. PubMed ID: 7247587 [TBL] [Abstract][Full Text] [Related]
4. [Fenquizone in the medium term treatment of essential hypertension. Double-blind comparison with chlorthalidone and placebo]. Pasotti C; Rossi R; Gandolfi P Minerva Med; 1981 Nov; 72(46):3105-10. PubMed ID: 7029355 [TBL] [Abstract][Full Text] [Related]
5. Long-acting and short-acting diuretics in the treatment of hypertension. Pupita F; Belogi M; Ansuini R; Campolucci G Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805 [TBL] [Abstract][Full Text] [Related]
6. Acute antihypertensive, diuretic and metabolic effects of etozolin and chlorthalidone. Nami R; Lucani B; Pavese G; Panza F; Moscato D; Martinelli M; Gennari C Panminerva Med; 1991; 33(3):157-63. PubMed ID: 1771100 [TBL] [Abstract][Full Text] [Related]
7. [Comparative studies of the effects of the diuretics, fenquizone and chlorthalidone, in arterial hypertension]. Bellini G; Battilana G; Carretta R; Bacci D; Fabris B; Menchini U G Clin Med; 1981 Feb; 62(2):119-28. PubMed ID: 7239056 [No Abstract] [Full Text] [Related]
8. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R; Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474 [TBL] [Abstract][Full Text] [Related]
9. [Hypertension--diuretics as antihypertensive agents]. Ikeda T Nihon Rinsho; 1970 Apr; 28(4):1266-71. PubMed ID: 4913896 [No Abstract] [Full Text] [Related]
10. The effects of metolazone in the long-term treatment of essential hypertension. Cangiano JL; Campos JA; Trevino A; Ramirez-Gonzalez R; Ramirez-Muzo O Curr Ther Res Clin Exp; 1974 Aug; 16(8):778-85. PubMed ID: 4217244 [No Abstract] [Full Text] [Related]
11. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647 [TBL] [Abstract][Full Text] [Related]
12. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients. Sung PK; Samet P; Yeh BK Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390 [No Abstract] [Full Text] [Related]
13. [Use of oxodoline in patients with arterial hypertension]. Mikunis RI; Serkova VK; Kaminskaia NA Klin Med (Mosk); 1988 Jan; 66(1):55-7. PubMed ID: 3283440 [No Abstract] [Full Text] [Related]
14. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker. Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666 [TBL] [Abstract][Full Text] [Related]
15. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U; Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186 [TBL] [Abstract][Full Text] [Related]
16. [Recent intervention studies with antihypertensive drugs and their influence on guidelines]. Rahn KH Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679 [TBL] [Abstract][Full Text] [Related]
17. Chlorthalidone - a renaissance in use? Sica DA Expert Opin Pharmacother; 2009 Sep; 10(13):2037-9. PubMed ID: 19663607 [TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive effects of clonidine and of the clonidine-chlorthalidone combination]. D'Amelio G; Dalla Volta S; De Longhi B; Razzolini R Minerva Med; 1974 May; 65(41):2342-9. PubMed ID: 4602117 [No Abstract] [Full Text] [Related]
19. [Diuretic therapy in the aged. A clinical comparison between two diuretic compounds]. Della Marchina MM; Renzi G; Serofilli S Minerva Med; 1981 Jan; 72(3):163-6. PubMed ID: 7207841 [TBL] [Abstract][Full Text] [Related]
20. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial]. Düsing R Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115 [No Abstract] [Full Text] [Related] [Next] [New Search]